Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:03PM ET
12.93
Dollar change
-1.24
Percentage change
-8.75
%
IndexRUT P/E- EPS (ttm)-2.38 Insider Own37.83% Shs Outstand45.92M Perf Week115.86%
Market Cap577.32M Forward P/E- EPS next Y-2.57 Insider Trans-0.33% Shs Float27.76M Perf Month62.44%
Income-104.70M PEG- EPS next Q-0.62 Inst Own65.47% Short Float12.80% Perf Quarter141.68%
Sales8.78M P/S65.75 EPS this Y1.04% Inst Trans-1.83% Short Ratio4.15 Perf Half Y231.54%
Book/sh3.47 P/B3.72 EPS next Y-8.97% ROA-43.23% Short Interest3.55M Perf Year61.02%
Cash/sh4.51 P/C2.87 EPS next 5Y- ROE-60.80% 52W Range3.35 - 16.40 Perf YTD145.82%
Dividend Est.- P/FCF- EPS past 5Y-44.06% ROI-63.71% 52W High-21.16% Beta0.77
Dividend TTM- Quick Ratio6.99 Sales past 5Y-5.84% Gross Margin46.15% 52W Low285.97% ATR (14)1.49
Dividend Ex-Date- Current Ratio6.99 EPS Y/Y TTM8.51% Oper. Margin-1307.05% RSI (14)75.17 Volatility22.53% 14.37%
Employees110 Debt/Eq0.04 Sales Y/Y TTM-29.21% Profit Margin-1192.34% Recom1.22 Target Price22.14
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q7.84% Payout- Rel Volume5.91 Prev Close14.17
Sales Surprise-23.54% EPS Surprise1.41% Sales Q/Q-14.29% EarningsMar 25 AMC Avg Volume855.99K Price12.93
SMA2075.64% SMA50113.42% SMA200114.13% Trades Volume2,877,225 Change-8.75%
Date Action Analyst Rating Change Price Target Change
Mar-26-24Upgrade TD Cowen Market Perform → Outperform
Nov-20-23Resumed JP Morgan Neutral
Jul-25-23Downgrade TD Cowen Outperform → Market Perform
May-01-23Upgrade BofA Securities Underperform → Neutral $9 → $12
Apr-26-23Resumed Canaccord Genuity Buy $24
Jan-06-23Downgrade BofA Securities Buy → Underperform $22 → $9
Oct-24-22Upgrade SVB Leerink Mkt Perform → Outperform $30
Jan-31-22Initiated Jefferies Buy $50
Dec-03-21Initiated BofA Securities Buy $43
Nov-22-21Upgrade JP Morgan Neutral → Overweight $41
Mar-27-24 11:40PM
08:50AM
Mar-26-24 04:07PM
11:20AM
07:54AM
07:49AM Loading…
07:49AM
Mar-25-24 09:53PM
05:10PM
04:01PM
04:01PM
Feb-29-24 08:50AM
Feb-26-24 10:00AM
Feb-25-24 01:37PM
Feb-19-24 02:31PM
Feb-15-24 09:55AM
06:59AM Loading…
06:59AM
Jan-17-24 04:30PM
Jan-08-24 08:00AM
Jan-04-24 04:30PM
Jan-02-24 10:29AM
Dec-14-23 09:55AM
Dec-01-23 09:00AM
Nov-21-23 08:00AM
Nov-09-23 05:48AM
Nov-07-23 07:00AM
Oct-17-23 04:30PM
Sep-21-23 08:00AM
Sep-20-23 04:30PM
Sep-05-23 07:00AM
Aug-16-23 01:00PM
06:02AM Loading…
Aug-08-23 06:02AM
Aug-07-23 08:15AM
07:00AM
Aug-02-23 08:00AM
Jul-25-23 02:32PM
07:00AM
Jul-21-23 07:30AM
Jul-05-23 01:20PM
Jun-21-23 04:22AM
Jun-16-23 04:30PM
Jun-14-23 09:55AM
May-09-23 09:55AM
06:04AM
May-06-23 08:03AM
May-04-23 10:00AM
08:55AM
07:00AM
May-03-23 08:00AM
May-02-23 10:02AM
Apr-25-23 07:00AM
Mar-28-23 10:40AM
Mar-15-23 07:00AM
Mar-06-23 08:15AM
07:00AM
Feb-27-23 04:30PM
Feb-07-23 08:00AM
Jan-26-23 05:59AM
Jan-09-23 08:00AM
Jan-04-23 08:00AM
Dec-02-22 09:00AM
Nov-29-22 07:30AM
Nov-14-22 01:02PM
08:25AM
07:00AM
Nov-10-22 08:32AM
07:30AM
Nov-07-22 09:55AM
Oct-19-22 10:02AM
Aug-25-22 07:30AM
Aug-19-22 06:40AM
Aug-10-22 09:55AM
Aug-09-22 11:54AM
Aug-08-22 08:15AM
07:00AM
Jun-01-22 02:00PM
07:30AM
May-12-22 07:44AM
May-10-22 07:00AM
May-05-22 10:06AM
May-02-22 04:35PM
Apr-07-22 07:30AM
Apr-05-22 07:30AM
Mar-10-22 07:00AM
Mar-01-22 09:43AM
Feb-28-22 10:00AM
07:30AM
Feb-10-22 10:00AM
Jan-13-22 11:13AM
Jan-11-22 11:56AM
Jan-10-22 01:20PM
08:11AM
07:00AM
Jan-04-22 07:30AM
Dec-03-21 10:00AM
Nov-30-21 09:16AM
Nov-22-21 07:20AM
Nov-19-21 11:54AM
Nov-08-21 07:00AM
Nov-04-21 11:28AM
Nov-03-21 07:30AM
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaye Edward M. MDCEOMar 19 '24Sale6.1011,15067,99969,350Mar 19 08:30 PM
Ticho BarryCHIEF MEDICAL OFFICERMar 19 '24Sale6.104,11625,10211,469Mar 19 08:34 PM
Tulipano Stephen JCFOMar 19 '24Sale6.104,11625,10220,746Mar 19 08:36 PM
Nash Huw M.COO & CBOMar 19 '24Sale6.104,11625,10211,329Mar 19 08:31 PM
Allan JonathanGENERAL COUNSEL & CORP SECMar 19 '24Sale6.102,34914,3267,724Mar 19 08:29 PM
Tulipano Stephen JCFOMar 15 '24Option Exercise0.0013,100024,862Mar 19 08:36 PM
Ticho BarryCHIEF MEDICAL OFFICERMar 15 '24Option Exercise0.0013,100015,585Mar 19 08:34 PM
Nash Huw M.COO & CBOMar 15 '24Option Exercise0.0013,100015,445Mar 19 08:31 PM
Kaye Edward M. MDCEOMar 15 '24Option Exercise0.0035,500080,500Mar 19 08:30 PM
Allan JonathanGENERAL COUNSEL & CORP SECMar 15 '24Option Exercise0.007,475010,073Mar 19 08:29 PM
Ticho BarryCHIEF MEDICAL OFFICERMar 01 '24Option Exercise0.605,5043,30212,485Mar 05 04:21 PM
Ticho BarryCHIEF MEDICAL OFFICERMar 01 '24Sale7.7510,00077,4692,485Mar 05 04:21 PM
TZIANABOS ARTHURDirectorFeb 13 '24Option Exercise2.1931,73969,50831,739Feb 15 04:17 PM
Ticho BarryCHIEF MEDICAL OFFICERFeb 01 '24Sale4.8010,00047,9916,981Feb 05 04:32 PM
Ticho BarryChief Medical OfficerJan 02 '24Sale5.7410,00057,35216,981Jan 04 04:38 PM
Ticho BarryChief Medical OfficerJul 03 '23Sale10.6015,000158,97325,895Jul 06 05:20 PM
Allan JonathanGeneral Counsel & Corp SecJun 21 '23Sale13.481,94826,2520Jun 23 04:45 PM
Ticho BarryChief Medical OfficerJun 01 '23Sale11.1315,000166,96440,895Jun 05 07:31 PM
Ticho BarryChief Medical OfficerMay 04 '23Sale10.006536,53055,895May 08 07:35 PM
Ticho BarryChief Medical OfficerMay 03 '23Sale10.1424,697250,36656,548May 03 08:04 PM
Ticho BarryChief Medical OfficerMay 02 '23Sale10.005,51355,13481,245May 03 08:04 PM
Ticho BarryChief Medical OfficerMay 01 '23Sale10.0024,967249,76786,758May 03 08:04 PM